CoChat

Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche

Open access
Govaere, Olivier, Wouters, Jasper, Petz, Michaela, Vandewynckel, Yves-Paul, Van den Eynde, Kathleen, Van den broeck, Anke, Verhulst, Stefaan, Dollé, Laurent, Gremeaux, Lies, Ceulemans, An, Nevens, Frederik, van Grunsven, Leo A., Topal, Baki, Vankelecom, Hugo, Giannelli, Gianluigi, Van Vlierberghe, Hans, Mikulits, Wolfgang, Komuta, Mina, Roskams, Tania · 2016 · Journal of Hepatology
Cited by 136

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND & AIMS: Cancer stem cells (CSCs) are thought to be persistent in tumours due to their chemoresistance and to cause relapse and metastasis. Hepatic carcinomas displaying hepatic progenitor cell (HPC) features have been associated with a poor prognosis, though it remains unclear how CSCs relate to these different histological subtypes. METHODS: Candidate CSCs were isolated using the side population (SP) technique from primary tissue samples diagnosed as keratin(K)19-negative or -positive hepatocellular carcinoma (HCC) or as combined hepatocellular/cholangiocarcinoma and analysed for gene and protein expression. The effect of laminin-332 was analysed in vitro by using HCC cell lines and in vivo using a xenograft mouse model. RESULTS: The size of the SP correlated with the degree of HPC features found in human hepatic cancer, and also showed an elevated mRNA expression of biliary/HPC markers and the extracellular matrix marker LAMC2, the gene encoding the laminin γ2-chain. Immunopositivity for the γ2-chain of laminin-332 was seen in the extracellular matrix surrounding small HPC-like tumour cells with a low proliferation rate. In vitro, laminin-332 increased K19 expression, phosphorylated mTOR and decreased phospho-histone H3 expression, indicating reduced cell mitosis. The effect of laminin-332 was enhanced upon mTORC1 inhibition and diminished when inhibiting mTORC1+C2. Resistance to doxorubicin and sorafenib treatment, and the SP fraction increased in the coated condition. In vivo, laminin-332 reduced tumour growth and sustained K19 expression. CONCLUSIONS: In this study we identified a prominent role for laminin-332 as part of the specialised CSC niche in maintaining and supporting cell 'stemness', which leads to chemoresistance and quiescence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2015.11.011

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 136

Metadata

Authors
Govaere, O., Wouters, J., Petz, M., Vandewynckel, Y.-P., Van den Eynde, K., Van den broeck, A., Verhulst, S., Dollé, L., Gremeaux, L., Ceulemans, A., Nevens, F., van Grunsven, L. A., Topal, B., Vankelecom, H., Giannelli, G., Van Vlierberghe, H., Mikulits, W., Komuta, M., & Roskams, T.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2016-03
Volume
64
Issue
3
Pages
609-617
ISSN
0168-8278 (ISSN-L)
OpenAlex
W2178003817
Cited by
136
References
4
FWCI
4.81
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche. https://app.cochat.ai/papers/10.1016/j.jhep.2015.11.011
The paper
Govaere, O., Wouters, J., Petz, M., Vandewynckel, Y.-P., Van den Eynde, K., Van den broeck, A., Verhulst, S., Dollé, L., Gremeaux, L., Ceulemans, A., Nevens, F., van Grunsven, L. A., Topal, B., Vankelecom, H., Giannelli, G., Van Vlierberghe, H., Mikulits, W., Komuta, M., & Roskams, T. (2016). Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2015.11.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.